Asymmetric corticomotor excitability correlations in early Parkinson's disease

Movement Disorders

Volumn 22, Issue 11, 2007, Pages 1587-1593

  Wu, Allan D ^a   Petzinger, Giselle M ^b,c   Lin, Chien Ho J ^c   Kung, Myron ^a   Fisher, Beth ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cortical excitability; Motor evoked potentials; Parkinson's disease; Silent period; Transcranial magnetic stimulation

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EVOKED MUSCLE RESPONSE; FEMALE; HUMAN; MALE; MOTOR CORTEX; NEUROPHYSIOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; AGED; AGED, 80 AND OVER; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTRIC STIMULATION; EVOKED POTENTIALS, MOTOR; FEMALE; HUMANS; INHIBITION (PSYCHOLOGY); MALE; MIDDLE AGED; MOTOR CORTEX; PARKINSON DISEASE; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 34748906797     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21565     Document Type: Article

References (42)

1. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 1973;20:415-455.
2. Bezard E, Gross CE, Brotchie JM. Presymptomatic compensation in Parkinson's disease is not dopamine-mediated. Trends Neurosci 2003;26:215-221.
3. Cantello R, Tarletti R, Civardi C. Transcranial magnetic stimulation and Parkinson's disease. Brain Res Brain Res Rev 2002;38:309-327.
4. Cantello R, Gianelli M, Bettucci D, Civardi C, De Angelis MS, Mutani R. Parkinson's disease rigidity: magnetic motor evoked potentials in a small hand muscle. Neurology 1991;41:1449-1456.
5. Ridding MC, Inzelberg R, Rothwell JC. Changes in excitability of motor cortical circuitry in patients with Parkinson's disease. Ann Neurol 1995;37:181-188.
6. Berardelli A, Rona S, Inghilleri M, Manfredi M. Cortical inhibition in Parkinson's disease. A study with paired magnetic stimulation. Brain 1996;119 (Part 1):71-77.
7. Valls-Sole J, Pascual-Leone A, Brasil-Neto JP, Cammarota A, McShane L, Hallett M. Abnormal facilitation of the response to transcranial magnetic stimulation in patients with Parkinson's disease. Neurology 1994;44:735-741.
8. Ellaway PH, Davey NJ, Maskill DW, Dick JP. The relation between bradykinesia and excitability of the motor cortex assessed using transcranial magnetic stimulation in normal and parkinsonian subjects. Electroencephalogr Clin Neurophysiol 1995;97:169-178.
9. Young MS, Triggs WJ, Bowers D, Greer M, Friedman WA. Stereotactic pallidotomy lengthens the transcranial magnetic cortical stimulation silent period in Parkinson's disease. Neurology 1997;49:1278-1283.
10. Chen R, Garg RR, Lozano AM, Lang AE. Effects of internal globus pallidus stimulation on motor cortex excitability. Neurology 2001;56:716-723.
11. Strafella AP, Valzania F, Nassetti SA, et al. Effects of chronic levodopa and pergolide treatment on cortical excitability in patients with Parkinson's disease: a transcranial magnetic stimulation study. Clin Neurophysiol 2000;111:1198-1202.
12. Djaldetti R, Ziv I, Melamed E. The mystery of motor asymmetry in Parkinson's disease. Lancet Neurol 2006;5:796-802.
13. Priori A, Berardelli A, Inghilleri M, Accornero N, Manfredi M. Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism. Brain 1994;117 (Part 2):317-323.
14. Kiers L, Cros D, Chiappa KH, Fang J. Variability of motor potentials evoked by transcranial magnetic stimulation. Electroencephalogr Clin Neurophysiol 1993;89:415-423.
15. Orth M, Rothwell JC. The cortical silent period: intrinsic variability and relation to the waveform of the transcranial magnetic stimulation pulse. Clin Neurophysiol 2004;115:1076-1082.
16. Devanne H, Lavoie BA, Capaday C. Input-output properties and gain changes in the human corticospinal pathway. Exp Brain Res 1997;114:329-338.
17. Kimiskidis VK, Papagiannopoulos S, Sotirakoglou K, Kazis DA, Kazis A, Mills KR. Silent period to transcranial magnetic stimulation: construction and properties of stimulus-response curves in healthy volunteers. Exp Brain Res 2005;163:21-31.
18. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971;9:97-113.
19. Brasil-Neto JP, Cohen LG, Panizza M, Nilsson J, Roth BJ, Hallett M. Optimal focal transcranial magnetic activation of the human motor cortex: effects of coil orientation, shape of the induced current pulse, and stimulus intensity. J Clin Neurophysiol 1992;9:132-136.
20. Koski L, Schrader LM, Wu AD, Stern JM. Normative data on changes in transcranial magnetic stimulation measures over a ten hour period. Clin Neurophysiol 2005;116:2099-2109.
21. Daskalakis ZJ, Molnar GF, Christensen BK, Sailer A, Fitzgerald PB, Chen R. An automated method to determine the transcranial magnetic stimulation-induced contralateral silent period. Clin Neurophysiol 2003;114:938-944.
22. Wassermann EM, Pascual-Leone A, Valls-Sole J, Toro C, Cohen LG, Hallett M. Topography of the inhibitory and excitatory responses to transcranial magnetic stimulation in a hand muscle. Electroencephalogr Clin Neurophysiol 1993;89:424-433.
23. Dioszeghy P, Hidasi E, Mechler F. Study of central motor functions using magnetic stimulation in Parkinson's disease. Electromyogr Clin Neurophysiol 1999;39:101-105.
24. Nakashima K, Wang Y, Shimoda M, Sakuma K, Takahashi K. Shortened silent period produced by magnetic cortical stimulation in patients with Parkinson's disease. J Neurol Sci 1995;130:209-214.
25. Manfredi L, Garavaglia P, Beretta S, Pellegrini G. Increased cortical inhibition induced by apomorphine in patients with Parkinson's disease. Neurophysiol Clin 1998;28:31-38.
26. Ziemann U, Bruns D, Paulus W. Enhancement of human motor cortex inhibition by the dopamine receptor agonist pergolide: evidence from transcranial magnetic stimulation. Neurosci Lett 1996;208:187-190.
27. Inghilleri M, Berardelli A, Marchetti P, Manfredi M. Effects of diazepam, baclofen and thiopental on the silent period evoked by transcranial magnetic stimulation in humans. Exp Brain Res 1996;109:467-472.
28. Cunic D, Roshan L, Khan FI, Lozano AM, Lang AE, Chen R. Effects of subthalamic nucleus stimulation on motor cortex excitability in Parkinson's disease. Neurology 2002;58:1665-1672.
29. Guekht A, Selikhova M, Serkin G, Gusev E. Implementation of the TMS in the early stages of Parkinson's disease. Electromyogr Clin Neurophysiol 2005;45:291-297.
30. DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990;13:281-285.
31. Tremblay F, Tremblay LE. Cortico-motor excitability of the lower limb motor representation: a comparative study in Parkinson's disease and healthy controls. Clin Neurophysiol 2002;113:2006-2012.
32. Pascual-Leone A, Valls-Sole J, Brasil-Neto JP, Cohen LG, Hallett M. Akinesia in Parkinson's disease. I. Shortening of simple reaction time with focal, single-pulse transcranial magnetic stimulation. Neurology 1994;44:884-891.
33. Chen R, Kumar S, Garg RR, Lang AE. Impairment of motor cortex activation and deactivation in Parkinson's disease. Clin Neurophysiol 2001;112:600-607.
34. Berardelli A, Rothwell JC, Thompson PD, Hallett M. Pathophys iology of bradykinesia in Parkinson's disease. Brain 2001;124(Part 11):2131-2146.
35. Lefaucheur JP. Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: influence of antiparkinsonian treatment and cortical stimulation. Clin Neurophysiol 2005;116:244-253.
36. Escola L, Michelet T, Macia F, Guehl D, Bioulac B, Burbaud P. Disruption of information processing in the supplementary motor area of the MPTP-treated monkey: a clue to the pathophysiology of akinesia? Brain 2003;126 (Part 1):95-114.
37. Cantello R, Gianelli M, Civardi C, Mutant R. Magnetic brain stimulation: the silent period after the motor evoked potential. Neurology 1992;42:1951-1959.
38. Boroojerdi B, Battaglia F, Muellbacher W, Cohen LG. Mechanisms influencing stimulus-response properties of the human corticospinal system. Clin Neurophysiol 2001;112:931-937.
39. Mavroudakis N, Caroyer JM, Brunko E, Zegers de Beyl D. Effects of vigabatrin on motor potentials evoked with magnetic stimulation. Electroencephalogr Clin Neurophysiol 1997;105:124-127.
40. Ziemann U. TMS and drugs. Clin Neurophysiol 2004;115:1717-1729.
41. Vila M, Herrero MT, Levy R, et al. Consequences of nigrostriatal denervation on the γ-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes. Neurology 1996;46:802-809.
42. Ondo WG, Hunter C. Flumazenil, a GABA antagonist, may improve features of Parkinson's disease. Mov Disord 2003;18:683-685.